BioHub, Inc.

Ground-Breaking Web Platform Revolutionizes Biomedical Research

    Toronto, July 6, 2010 (ots/PRNewswire) - BioHub Inc., announced today the launch of, a first-of- its-kind online platform to facilitate global networking and collaboration  among research scientists.

    Antibodies are biomedical research reagents used for hundreds of thousands of experiments globally. The global market for research antibodies exceeds $2 billion, yet independent studies show that less than  50% of commercial antibodies are of adequate quality, leading to  compromised results and wasted time and resources. Developed to respond to  this problem, is a web-based networking tool that not  only serves as a comprehensive listing of over 100,000 antibody products,  but also provides researchers with the opportunity to provide product  reviews. Taken together, will allow scientists to make  informed decisions, thus increasing the efficiency of biomedical research.

    Motivated to advocate product excellence and transparency within the  biomedical marketplace, Alex Hodgson, co-founder of BioHub remarked, "We as  a community need to support those companies who go that extra mile to bring  us top-quality products and hold those that don't accountable." has already won the support of leading researchers,  including Dr. Aled Edwards (Structural Genomics Consortium), Dr. Sachdev  Sidhu (University of Toronto), Dr. Brian Marsden (University of Oxford) and  Dr. Lori Frappier (Canada Research Chair in Virology). "Antibodies are  among the most commonly used reagents in biomedicine, yet are subjected to  the least effective quality control. BioHub will create order from this  chaos by empowering the scientific community to communicate their reviews of commercial products," says Dr. Aled Edwards.

    BioHub promises to not only create a channel of direct feedback between scientists and antibody providers, but also creates opportunities  for users to connect with each other. Two of BioHub's community features  include: BioAlerts, which lets users know when new antibodies and data have  been uploaded for specific targets, while BioMessenger enables users to  send direct messages to other users to facilitate follow-on collaborations.

    About BioHub, Inc.    

    BioHub, Inc. is a privately owned Canadian corporation that operates, an open-access online platform designed to meet the  needs of the biomedical research community. BioHub enables users to connect  with colleagues, discover which products work best for specific  applications, share experiences and collaborate online.

    For additional information on, contact Alex Hodgson  (+1-647-981-2461/ or visit

    For further information: Alexandra Hodgson, 117-112 College Street,  Toronto, ON, Canada, M5G 1L6, Email:, Tel:  +1-647-981-2461

ots Originaltext: BioHub, Inc.
Im Internet recherchierbar:

CONTACT:  For further information: Alexandra Hodgson, 117-112
CollegeStreet, Toronto, ON, Canada, M5G 1L6, Email:, Tel:+1-647-981-2461

Das könnte Sie auch interessieren: